The Biscayan firm Gogoa Mobility Robots designs and develops robotic devices aimed at the medical and social-health, industrial, sports or military sectors. Founded in 2015, it has a turnover of 1.5 million euros.

Biomedical engineering Gogoa Mobility Robots has recently launched 'Belk+' on the market, a new robotic device that reacts and assists the user's intention to move. The Basque firm, dedicated to the research, design and development of high-tech lightweight exoskeletons, has expanded with the new device its series of intelligent exoskeletons aimed at the medical (neurorehabilitation), socio-health, industrial, sports or military sectors.

The new product, the first of its kind developed in Europe, has been designed to provide a new level of independence for people with reduced mobility, regardless of their age. “The device adapts to the user's gait, allowing a comfortable and totally natural walking experience,” highlights Galder Arego, head of marketing and brand strategy at Gogoa Mobility Robots.

The new exoskeleton is aimed at people seeking to regain mobility and achieve a natural gait by assisting their legs. Its low weight, ease of use and the digitalization of the device, with small motors to effectively strengthen the functionality of the knee joints, "make this product a very useful tool in the daily life of people with reduced mobility,” he acknowledges. In addition, the electrical equipment has a quick charging function that allows it to be used for a full day. And it helps to walk on different terrains, including ramps and stairs.

Recovery from motor problems

The Biscayan company, founded in 2015, designs and applies comprehensive treatments “aimed at the recovery of motor problems in people with different pathologies such as stroke, spinal cord injury, neurodegenerative diseases or muscle dysfunctions,” Arego details. In this sense, he adds to technology the therapies that he designs in his Urretxu clinic 'Movex Living Lab', "the world's first laboratory for the design of neurorehabilitation therapies," underlines the company representative.

The Basque firm manufactures medical exoskeletons for the rehabilitation of gait or mobility of hands and arms, social health and personal use. “And, in addition, we offer robotic neurorehabilitation therapies in our clinics,” he says.

His flagship product is the 'Hank' exoskeleton, “the most technologically advanced device for lower limbs, the only one in the world with six motorized joints and an adaptive gait pattern,” he lists. In addition, Arego highlights that “it is the first European exoskeleton to obtain the CE marking as a medical product.”

For Gogoa Mobility Robots “innovation is one of our pillars and one of our four values ​​along with efficiency, commitment and inclusion,” he acknowledges. In this sense, he has participated in several strategic projects within the SPRI Group's Hazitek aid program, “which has allowed us to develop technology that we are incorporating into our products,” he points out.

The Biscayan company, which had a turnover of 1.5 million euros in 2023, operates mainly in the state market. “We are making our first forays into the French or German market, and we have developed commercial actions in Latin American countries such as Panama, Colombia or Mexico,” Galder Arego advances.

Currently, the staff is made up of 17 people at Gogoa Mobility Robost and 4 at the Movex clinics. “We have just hired two new people and the plan is to continue expanding the workforce in the short-medium term, since the company is growing,” says the head of marketing and brand strategy.